These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 32385781)
21. Cystatin C as a marker of early renal insufficiency in children with congenital neuropathic bladder. Fox JA; Dudley AG; Bates C; Cannon GM J Urol; 2014 May; 191(5 Suppl):1602-7. PubMed ID: 24679869 [TBL] [Abstract][Full Text] [Related]
22. Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetes. Perkins BA; Rabbani N; Weston A; Ficociello LH; Adaikalakoteswari A; Niewczas M; Warram J; Krolewski AS; Thornalley P PLoS One; 2012; 7(4):e35655. PubMed ID: 22558190 [TBL] [Abstract][Full Text] [Related]
23. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Coll E; Botey A; Alvarez L; Poch E; Quintó L; Saurina A; Vera M; Piera C; Darnell A Am J Kidney Dis; 2000 Jul; 36(1):29-34. PubMed ID: 10873868 [TBL] [Abstract][Full Text] [Related]
24. Long-term follow-up of renal function assessing serum cystatin C in dogs with diabetes mellitus or hyperadrenocorticism. Marynissen SJ; Smets PM; Ghys LF; Paepe D; Delanghe J; Galac S; Meyer E; Lefebvre HP; Daminet S Vet Clin Pathol; 2016 Jun; 45(2):320-9. PubMed ID: 27228235 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of serum cystatin C and chromogranin A as markers of nephropathy in patients with type 2 diabetes mellitus. Mojiminiyi OA; Abdella N; George S Scand J Clin Lab Invest; 2000 Oct; 60(6):483-9. PubMed ID: 11129064 [TBL] [Abstract][Full Text] [Related]
26. GFR estimation using standardized cystatin C in kidney transplant recipients. Masson I; Maillard N; Tack I; Thibaudin L; Dubourg L; Delanaye P; Cavalier E; Bonneau C; Kamar N; Morelon E; Moranne O; Alamartine E; Mariat C Am J Kidney Dis; 2013 Feb; 61(2):279-84. PubMed ID: 23141866 [TBL] [Abstract][Full Text] [Related]
27. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes. Oddoze C; Morange S; Portugal H; Berland Y; Dussol B Am J Kidney Dis; 2001 Aug; 38(2):310-6. PubMed ID: 11479157 [TBL] [Abstract][Full Text] [Related]
28. Cystatin C as an early marker of diabetic nephropathy in patients with type 2 diabetes. Jeon YL; Kim MH; Lee WI; Kang SY Clin Lab; 2013; 59(11-12):1221-9. PubMed ID: 24409655 [TBL] [Abstract][Full Text] [Related]
29. GFR prediction from cystatin C and creatinine in children: effect of including body cell mass. Andersen TB; Jødal L; Boegsted M; Erlandsen EJ; Morsing A; Frøkiær J; Brøchner-Mortensen J Am J Kidney Dis; 2012 Jan; 59(1):50-7. PubMed ID: 22037490 [TBL] [Abstract][Full Text] [Related]
30. Microalbuminuria, but not cystatin C, is associated with carotid atherosclerosis in middle-aged adults. Rodondi N; Yerly P; Gabriel A; Riesen WF; Burnier M; Paccaud F; Bovet P Nephrol Dial Transplant; 2007 Apr; 22(4):1107-14. PubMed ID: 17205961 [TBL] [Abstract][Full Text] [Related]
31. Serum cystatin C is independently associated with renal impairment and high sensitivity C-reactive protein in systemic lupus erythematosus. Chew C; Pemberton PW; Husain AA; Haque S; Bruce IN Clin Exp Rheumatol; 2013; 31(2):251-5. PubMed ID: 23306163 [TBL] [Abstract][Full Text] [Related]
32. Association of serum resistin with cystatin C and urinary albumin-to-creatinine ratio in elderly Chinese men with essential hypertension. Zhang M; Cui H; Zhu BP; Fu SH Postgrad Med J; 2015 Mar; 91(1073):132-7. PubMed ID: 25677700 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of the clinical application of cystatin C, a new marker of the glomerular filtration rate, for the initial dose-setting of arbekacin. Otsuka T; Tanaka A; Suemaru K; Inoue T; Nishimiya T; Murase M; Araki H J Clin Pharm Ther; 2008 Jun; 33(3):227-35. PubMed ID: 18452409 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of creatinine-based and cystatin C-based equations for estimation of glomerular filtration rate in type 1 diabetic patients. Domingueti CP; Fóscolo RB; Simões E Silva AC; Dusse LM; Reis JS; Carvalho Md; Fernandes AP; Gomes KB Arch Endocrinol Metab; 2016 Apr; 60(2):108-16. PubMed ID: 27191046 [TBL] [Abstract][Full Text] [Related]
35. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. Kramer HJ; Nguyen QD; Curhan G; Hsu CY JAMA; 2003 Jun; 289(24):3273-7. PubMed ID: 12824208 [TBL] [Abstract][Full Text] [Related]
36. Reference intervals for serum cystatin C and serum creatinine in an adult sub-Saharan African population. Edinga-Melenge BE; Yakam AT; Nansseu JR; Bilong C; Belinga S; Minkala E; Noudjeu PA; Ondhoua M; Kokola SW; Ama Moor VJ; Ashuntantang G BMC Clin Pathol; 2019; 19():4. PubMed ID: 30923459 [TBL] [Abstract][Full Text] [Related]
37. Is serum cystatin C an accurate endogenous marker of glomerular filteration rate for detection of early renal impairment in patients with type 2 diabetes mellitus? El-Shafey EM; El-Nagar GF; Selim MF; El-Sorogy HA; Sabry AA Ren Fail; 2009; 31(5):355-9. PubMed ID: 19839834 [TBL] [Abstract][Full Text] [Related]
38. Use of serum cystatin C to detect early decline of glomerular filtration rate in type 2 diabetes. Yang YS; Peng CH; Lin CK; Wang CP; Huang CN Intern Med; 2007; 46(12):801-6. PubMed ID: 17575370 [TBL] [Abstract][Full Text] [Related]
39. Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus. Vijay S; Hamide A; Senthilkumar GP; Mehalingam V Diabetes Metab Syndr; 2018 Sep; 12(5):649-652. PubMed ID: 29673928 [TBL] [Abstract][Full Text] [Related]
40. Serum cystatin C and microalbuminuria in the detection of vascular and renal damage in early stages. López Gómez JM; Sacristán Enciso B; Micó M; Arias Meneses F; de Sande Medel F; Alejo S Nefrologia; 2011; 31(5):560-6. PubMed ID: 21959722 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]